Evaluation of the analytical performance of anti-SARS-CoV-2 antibody test kits distributed or developed in Japan

Bioanalysis. 2022 Mar;14(6):325-340. doi: 10.4155/bio-2021-0254. Epub 2022 Mar 2.

Abstract

Background: With the spread of COVID-19, anti-SARS-CoV-2 antibody tests have been utilized. Herein we evaluated the analytical performance of anti-SARS-CoV-2 antibody test kits using a new reference standard prepared from COVID-19 patient sera. Methods: Fifty-seven kits in total (16 immunochromatography types, 11 ELISA types and 30 types for automated analyzers) were examined. By measuring serially diluted reference standards, the maximum dilution factor showing a positive result and its precision were investigated. Results: The measured cut-off titers varied largely depending on the antibody kit; however, the variability was small, with the titers obtained by each kit being within twofold in most cases. Conclusion: The current results suggest that a suitable kit should be selected depending on the intended purpose.

Keywords: ELISA; analytical performance; anti-SARS-CoV-2 antibody test; antibody titer; automated analyzer; cut-off titer; cut-off value; immunochromatography.

Publication types

  • Evaluation Study

MeSH terms

  • Antibodies, Viral / blood
  • Automation, Laboratory
  • COVID-19 Serological Testing / instrumentation
  • COVID-19 Serological Testing / methods*
  • COVID-19 Serological Testing / standards
  • Enzyme-Linked Immunosorbent Assay / instrumentation
  • Enzyme-Linked Immunosorbent Assay / methods
  • Humans
  • Immunoglobulin G / blood
  • Japan
  • Reagent Kits, Diagnostic*
  • SARS-CoV-2 / immunology

Substances

  • Antibodies, Viral
  • Immunoglobulin G
  • Reagent Kits, Diagnostic